Form 3 - Initial statement of beneficial ownership of securities
05 Agosto 2024 - 9:38AM
Edgar (US Regulatory)
POWER OF ATTORNEY
FOR SEC FILINGS ON FORMS ID, 3, 4, 5 AND 144
IN RESPECT OF SECURITIES OF
GALECTIN THERAPEUTICS INC.
The undersigned hereby constitutes and appoints each of Jack W. Callicutt and Joel Lewis as his true and lawful
attorney-in-fact and agent, with full power of substitution and resubstitution for him in his name and stead in any and all capacities, to sign and file for and on her behalf, in respect of any acquisition, disposition or other change in ownership
of any Common Stock or derivative securities thereof of Galectin Therapeutics Inc. (the "Company"), the following:
(i)
|
any Form ID to be filed with the Securities and Exchange Commission (the "SEC");
|
(ii)
|
any Initial Statement of Beneficial Ownership of Securities on Form 3 to be filed with the SEC;
|
(iii)
|
any Statement of Changes of Beneficial Ownership of Securities on Form 4 to be filed with the SEC;
|
(iv)
|
any Annual Statement of Beneficial Ownership of Securities on Form 5 to be filed with the SEC;
|
(v)
|
any Notice of Proposed Sale of Securities on Form 144 to be filed with the SEC; and
|
(vi)
|
any and all agreements, certificates, receipts, or other documents in connection therewith. The undersigned hereby gives full power and authority to
the attorney-in-fact to seek and obtain as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any third party, including brokers, employee benefit plan
administrators and trustees, and the undersigned hereby authorizes any such person to release such information to the undersigned and approves and ratifies any such release of information. The undersigned hereby grants unto such
attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary in connection with such matters and hereby ratifies and confirms all that any such attorney-in-fact and agent or
substitute may do or cause to be done by virtue hereof. The undersigned acknowledges that:
|
(i)
|
neither the Company nor such attorney-in-fact assumes (i) any liability for the undersigned's responsibility to comply with the
requirement of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), (ii) any liability of the undersigned for any failure to comply with such requirements or (iii) any obligation or liability of the undersigned for profit
disgorgement under Section 16(b) of the Exchange Act; and
|
(ii)
|
this Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations
under the Exchange Act, including without limitation the reporting requirements under Section 16 of the Exchange Act. This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing
delivered to such attorney-in-fact.
|
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney.
Date: July 29, 2024 /s/ Khurram Jamil
Khurram Jamil
Galectin Therapeutics (NASDAQ:GALT)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Galectin Therapeutics (NASDAQ:GALT)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024